Long-term Benefits of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Severe Immunoglobulin A Nephropathy: A Comparison to Patients Receiving Treatment With Other Antihypertensive Agents and to Patients Receiving No Therapy

Enzyme Inhibitor ◽

Immunoglobulin A ◽

Antihypertensive Agents ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Immunoglobulin A Nephropathy ◽

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin-converting Enzyme Inhibitor

The American Journal of Medicine ◽

10.1016/j.amjmed.2012.06.028 ◽

2013 ◽

Vol 126 (2) ◽

pp. 162-168 ◽

Cited By ~ 12

Author(s):

Philip Kam-Tao Li ◽

Bonnie Ching-Ha Kwan ◽

Kai-Ming Chow ◽

Chi-Bon Leung ◽

Cheuk-Chun Szeto

Keyword(s):

Enzyme Inhibitor ◽

Immunoglobulin A ◽

Converting Enzyme ◽

Immunoglobulin A Nephropathy ◽

P2803 NEP inhibition potentiates bradykinin-mediated vasodilatation in patients with heart failure on long-term angiotensin-converting enzyme inhibitor therapy

European Heart Journal ◽

10.1016/s0195-668x(03)95581-3 ◽

2003 ◽

Vol 24 (5) ◽

pp. 528

Author(s):

N CRUDEN

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Patients With Heart Failure ◽

Nep Inhibition

Unrecognized recurrent perioperative angioedema requiring intubation in a patient taking long-term angiotensin-converting enzyme inhibitor therapy

Otolaryngology Case Reports ◽

10.1016/j.xocr.2021.100389 ◽

2021 ◽

pp. 100389

Author(s):

Christopher Wojcik ◽

Brian Farrell

Keyword(s):

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Faculty Opinions recommendation of Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy: An Avoidable but Common Error.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725687474.793513300 ◽

2016 ◽

Author(s):

Lars C Huber

Keyword(s):

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Common Error ◽

Serum Angiotensin Converting Enzyme ◽

Enzyme Test

Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients: A quinapril to quinaprilat placebo-controlled model

European Heart Journal ◽

10.1093/oxfordjournals.eurheartj.a015096 ◽

1997 ◽

Vol 18 (1) ◽

pp. 140-147 ◽

Cited By ~ 1

Author(s):

A. Whelton ◽

L. McCormick ◽

D. Wombolt ◽

R. Goldstein ◽

D. Canter

Keyword(s):

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Short Term ◽

Hypertensive Patients ◽

Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin‐converting enzyme inhibitor therapy

Pharmacoepidemiology and Drug Safety ◽

10.1002/pds.5361 ◽

2021 ◽

Author(s):

Elizabeth T. Mansi ◽

Eric S. Johnson ◽

Micah L. Thorp ◽

Alan S. Go ◽

Ming‐Sum Lee ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Diagnosis Codes ◽

Patients With Heart Failure

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

Journal of Hypertension ◽

10.1097/hjh.0b013e328341d117 ◽

2011 ◽

Vol 29 (3) ◽

pp. 509-519 ◽

Cited By ~ 35

Author(s):

Jasper J Brugts ◽

Aaron Isaacs ◽

Moniek PM de Maat ◽

Eric Boersma ◽

Cock M van Duijn ◽

...

Keyword(s):

Blood Pressure ◽

Vascular Disease ◽

Enzyme Inhibitor ◽

Blood Pressure Response ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Healthy Individuals ◽

Long-Term Combined Therapy with an Angiotensin Type I Receptor Blocker and an Angiotensin Converting Enzyme Inhibitor Prolongs Survival in Dilated Cardiomyopathy.

Japanese Heart Journal ◽

10.1536/jhj.43.531 ◽

2002 ◽

Vol 43 (5) ◽

pp. 531-543 ◽

Cited By ~ 6

Author(s):

Toshihiro Shimizu ◽

Hiroshi Okamoto ◽

Satoru Chiba ◽

Yutaka Matsui ◽

Takeshi Sugawara ◽

...

Keyword(s):

Dilated Cardiomyopathy ◽

Enzyme Inhibitor ◽

Combined Therapy ◽

Type I ◽

Converting Enzyme ◽

Angiotensin Type

Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction

New England Journal of Medicine ◽

10.1056/nejm200105033441802 ◽

2001 ◽

Vol 344 (18) ◽

pp. 1351-1357 ◽

Cited By ~ 387

Author(s):

Derek V. Exner ◽

Daniel L. Dries ◽

Michael J. Domanski ◽

Jay N. Cohn

Keyword(s):

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

White Patients

Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy

CHEST Journal ◽

10.1378/chest.15-1061 ◽

2015 ◽

Vol 148 (6) ◽

pp. 1447-1453 ◽

Cited By ~ 13

Author(s):

Matthew D. Krasowski ◽

Johanna Savage ◽

Alexandra Ehlers ◽

Jon Maakestad ◽

Gregory A. Schmidt ◽

...

Keyword(s):

Enzyme Inhibitor ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Serum Angiotensin Converting Enzyme ◽

Enzyme Test